Received May 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | AK334 | — |
a vaccine given to a 2 years old, it was the Boostrix instead of the infanrix; a vaccine given to a 2 years old, it was the Boostrix instead of the infanrix; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong vaccine administered in a 2-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number AK334, expiry date 14-JUN-2027) for prophylaxis. Co-suspect products included DTPa (Infanrix) for prophylaxis. On 30-APR-2025, the patient received the 1st dose of Boostrix. On an unknown date, the patient received Infanrix. On 30-APR-2025, an unknown time after receiving Boostrix and not applicable after receiving Infanrix, the patient experienced wrong vaccine administered (Verbatim: a vaccine given to a 2 years old, it was the Boostrix instead of the infanrix) and inappropriate age at vaccine administration (Verbatim: a vaccine given to a 2 years old, it was the Boostrix instead of the infanrix). The outcome of the wrong vaccine administered and inappropriate age at vaccine administration were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 01-MAY-2025 Registered Nurse reported that yesterday, there was a vaccine given to a 2 years old, it was the Boostrix instead of the Infanrix, which led to Wrong vaccine administered and Inappropriate age at vaccine administration. And reporter was just wanting to see if there are any adverse reactions or anything that need to do on our end besides the incident report. The reporter Consented to follow up. HCP stated that the 2 years old patient was supposed to receive the 4th dose of Infanrix.